Diabetes, B-Cell Preservation, Exercise and Insulin-Induced Lipoatrophy with Dr Parth Narendran

I talk shop with one of the World’s leading researchers Type 1 diabetes Dr Parth Narendran on a wide range of topics about Type 1 and Type 2 diabetes.

We discuss:

• Interesting research findings in respect to exercise and immunology?
• Just how beneficial is exercise for people with diabetes?
• Why is there limited exercise research in people with type 1 diabetes?
• How does exercise protect remaining b-cell function?
• Exercise and its ability to extend the honeymoon period.
• What is the biggest fear/challenge people with diabetes have regarding exercise that you see in your clinical practice?
• Key tips for managing blood glucose around strength training and low intensity cardio.
• Is lipoatrophy permanent? What can be done about it?
• The most exciting and promising future therapy for people with type 1 diabetes?
• Parth’s insights into writing the NICE MIB 101 Freestyle Libre guidance documents.
• Parth’s biggest piece of advice for people living with type 1 and type 2 diabetes.
• And more…

More About Parth.

Parth is a qualified clinician by background. His research is primarily on type 1 diabetes, in particular on how to preserve the function of insulin producing pancreatic beta cells.

He is currently the co-lead for the West Midlands Clinical Research Network and was previously the diabetes theme lead for the Birmingham and Black Country Clinical Research Network from 2010-14. He leads the Diabetes Research Unit and the Type 1 Diabetes clinical service at the Queen Elizabeth Hospital. He is the author of over 50 peer-reviewed publications including ones which have been cited by international bodies on Type 1 diabetes and its management. He currently sits on the Regional Advisory Committee for the NIHR RfPB programme and was previously on the Research Advisory Board of the Diabetes Research and Wellness Foundation (2009-11). He currently sits on the Profession Conference Organising Committee for Diabetes UK. Parth reviews for all the major national and international diabetes journals and contributes to the NIHR Horizon Scanning Research and Intelligence centre for new therapies.